These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34854884)

  • 1. Gut microbiota-driven brain Aβ amyloidosis in mice requires microglia.
    Dodiya HB; Lutz HL; Weigle IQ; Patel P; Michalkiewicz J; Roman-Santiago CJ; Zhang CM; Liang Y; Srinath A; Zhang X; Xia J; Olszewski M; Zhang X; Schipma MJ; Chang EB; Tanzi RE; Gilbert JA; Sisodia SS
    J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34854884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms.
    Chandra S; Di Meco A; Dodiya HB; Popovic J; Cuddy LK; Weigle IQ; Zhang X; Sadleir K; Sisodia SS; Vassar R
    Mol Neurodegener; 2023 Jul; 18(1):45. PubMed ID: 37415149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.
    Bosch ME; Dodiya HB; Michalkiewicz J; Lee C; Shaik SM; Weigle IQ; Zhang C; Osborn J; Nambiar A; Patel P; Parhizkar S; Zhang X; Laury ML; Mondal P; Gomm A; Schipma MJ; Mallah D; Butovsky O; Chang EB; Tanzi RE; Gilbert JA; Holtzman DM; Sisodia SS
    Mol Neurodegener; 2024 Feb; 19(1):18. PubMed ID: 38365827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes.
    Dodiya HB; Kuntz T; Shaik SM; Baufeld C; Leibowitz J; Zhang X; Gottel N; Zhang X; Butovsky O; Gilbert JA; Sisodia SS
    J Exp Med; 2019 Jul; 216(7):1542-1560. PubMed ID: 31097468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational profiling identifies sex-specific metabolic and epigenetic reprogramming of cortical microglia/macrophages in APPPS1-21 mice with an antibiotic-perturbed-microbiome.
    Shaik SM; Cao Y; Gogola JV; Dodiya HB; Zhang X; Boutej H; Han W; Kriz J; Sisodia SS
    Mol Neurodegener; 2023 Dec; 18(1):95. PubMed ID: 38104136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in APPPS1-21 Alzheimer's transgenic mice.
    Dodiya HB; Frith M; Sidebottom A; Cao Y; Koval J; Chang E; Sisodia SS
    Sci Rep; 2020 May; 10(1):8183. PubMed ID: 32424118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APP
    Minter MR; Hinterleitner R; Meisel M; Zhang C; Leone V; Zhang X; Oyler-Castrillo P; Zhang X; Musch MW; Shen X; Jabri B; Chang EB; Tanzi RE; Sisodia SS
    Sci Rep; 2017 Sep; 7(1):10411. PubMed ID: 28874832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effect of ACI-24 Vaccination on Aβ Plaque Pathology and Microglial Phenotypes in an Amyloidosis Mouse Model.
    Rudan Njavro J; Vukicevic M; Fiorini E; Dinkel L; Müller SA; Berghofer A; Bordier C; Kozlov S; Halle A; Buschmann K; Capell A; Giudici C; Willem M; Feederle R; Lichtenthaler SF; Babolin C; Montanari P; Pfeifer A; Kosco-Vilbois M; Tahirovic S
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer's disease.
    Mezö C; Dokalis N; Mossad O; Staszewski O; Neuber J; Yilmaz B; Schnepf D; de Agüero MG; Ganal-Vonarburg SC; Macpherson AJ; Meyer-Luehmann M; Staeheli P; Blank T; Prinz M; Erny D
    Acta Neuropathol Commun; 2020 Jul; 8(1):119. PubMed ID: 32727612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer's Disease: A Targeted Transcriptome Analysis.
    Ma C; Hunt JB; Kovalenko A; Liang H; Selenica MB; Orr MB; Zhang B; Gensel JC; Feola DJ; Gordon MN; Morgan D; Bickford PC; Lee DC
    Front Immunol; 2021; 12():628156. PubMed ID: 34046031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
    Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
    J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation.
    Kim H; Lee E; Park M; Min K; Diep YN; Kim J; Ahn H; Lee E; Kim S; Kim Y; Kang YJ; Jung JH; Byun MS; Joo Y; Jeong C; Lee DY; Cho H; Park H; Kim T
    Brain Behav Immun; 2024 Nov; 122():568-582. PubMed ID: 39197546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative approach to sporadic Alzheimer's disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden.
    Haure-Mirande JV; Wang M; Audrain M; Fanutza T; Kim SH; Heja S; Readhead B; Dudley JT; Blitzer RD; Schadt EE; Zhang B; Gandy S; Ehrlich ME
    Mol Psychiatry; 2019 Mar; 24(3):431-446. PubMed ID: 30283032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis.
    Ben-Nejma IRH; Keliris AJ; Daans J; Ponsaerts P; Verhoye M; Van der Linden A; Keliris GA
    Acta Neuropathol Commun; 2019 Nov; 7(1):180. PubMed ID: 31727182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
    Novotny R; Langer F; Mahler J; Skodras A; Vlachos A; Wegenast-Braun BM; Kaeser SA; Neher JJ; Eisele YS; Pietrowski MJ; Nilsson KP; Deller T; Staufenbiel M; Heimrich B; Jucker M
    J Neurosci; 2016 May; 36(18):5084-93. PubMed ID: 27147660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease.
    Song M; Jin J; Lim JE; Kou J; Pattanayak A; Rehman JA; Kim HD; Tahara K; Lalonde R; Fukuchi K
    J Neuroinflammation; 2011 Aug; 8():92. PubMed ID: 21827663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
    Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
    Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.